Skip to content
Climb Bio, Inc. logo

Climb Bio, Inc. (CLYM) Q1 2024 Annual Earnings

CLYM·Reported May 15, 2024·Before market open

Diluted EPS came in at $-0.06.

Diluted EPS
$-0.06
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q1 2024

Q1 2024 Earnings FAQ

Common questions about Climb Bio, Inc.'s Q1 2024 earnings report.

Climb Bio, Inc. (CLYM) reported Q1 2024 earnings on May 15, 2024 before market open.

Climb Bio, Inc. reported diluted EPS of $-0.06 for Q1 2024.

You can read the 10-K/A periodic report (0001193125-24-122192) directly on SEC EDGAR. The filing index links above go to sec.gov.